Use of parenteral lipid emulsions in French neonatal ICUs.
Détails
ID Serval
serval:BIB_8387E0A06132
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Use of parenteral lipid emulsions in French neonatal ICUs.
Périodique
Nutrition in Clinical Practice
Contributeur⸱rice⸱s
French neonatal departments, Tahar HA., Allisy C., Arnault I., Astruc D., Auburtin B., Aujard Y., Barré P., Barre V., Bazin P., Benbrik N., Benezech C., Bengrina M., Bessis JL., Betremieux P., de La Pintière A., Biran-Mucignat V., Blanc JF., Blanchot I., Bolot P., Bonnemaison JJ., Bossard G., Bouillié J., Bréant I., Brossier JP., Callamand P., Cambier F., Carlus C., Casagrande F., Cazassus F., Cécile W., Chevalier J., Chevret L., Chognot D., Chomienne F., Claris O., Coatantiec Y., Condor R., Cottacin G., Coudy-Angelvy C., Couronne M., Cuzzi J., Debillon T., de Gamarra E., de Gennes C., Delaporte£££Benoît£££ B. , Marque Rde L., Zamba B., Renouard-Pazat J., Delepoulle F., Robin E., Delgado M., Deliege R., de Montgolfier I., Descombes-Barroso E., Deslypper A., Desnoulez L., Robert CD., Devulder C., Dieckmann K., Dobrzynski M., Doeuvre P., Douard P., Dupic Y., Dupuy RP., Duret JF., Faverge B., Favreau A., Lakhdari Y., Feldmann M., Ferracci JP., Fieschi JB., Flori J., Flurin V., Franc M., Françoise M., Freysz H., Froute MF., Fury H., Gagliardone C., Giudicelli H., Glorieux I., Gothié I., Gouedard H., Goumy P., Guillot F., Guilluy O., Guinchard A., Hamza A., Harvey B., Hay-Fendler F., Hervé F., Hubert S., Hureaux A., Jeannot E., Jouvencel P., Juchereau M., Keller L., Ketterer-Martinon S., Kieffer F., Klosowski S., Lachassinne E., Laisney N., Lamireau D., Lapeyre F., Le Bouedec S., Lecomte B., Le Gall MA. , Lehnert A., Léké A., Goudjil S., Lenclen R., Leraillez J., Leyronnas D., Lhermitte-Cahuzac C., Maingueneau C., Malgorn G., Manchart JP., Mandel R., Mansir T., Mariette JB., Marquet L., Dinard JM., Masson P., Menaud G., Menu-Guillemin S., Mettey R., Meunier M., Miguet D., Millet V., Simeoni U., Mitanchez D., Monfort P., Mpeti B., Morice C., Moulie N., Muller S., Mussat P., Nicaise C., Obegi C., Ouchtati M., Pailhé L., Rauzy MP., Pawlotsky F., Patkaï J., Pecheur H., Picaud JC., Pierre G., Pignol ML., Pincemaille O., Pinquier D., Pradeaux L., Provot E., Puech JR., Putet G., Racoussot S., Rakza T., Razafimahefa H., Rebaud P., Renolleau S., Rimet Y., Rivière MF., Robillard PY., Ropert JC., Rousseau S., Rudler J., Rugemintwaza D., Santerne B., Sanyas P., Saunier P., Seaume H., Semama D., Somerville D., Soulier JL., Spitz C., Taïma A., Tamboura A., Tessier R., Testard H., Theret B., Thevenot P., Thiriez G., Tronc F., Vaillant JM., Vermeulin C., Walther M.
ISSN
1941-2452 (Electronic)
ISSN-L
0884-5336
Statut éditorial
Publié
Date de publication
2011
Peer-reviewed
Oui
Volume
26
Numéro
6
Pages
672-680
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't Publication Status: ppublish
Résumé
OBJECTIVE: To determine the types of parenteral lipid emulsions currently used for preterm infants, their mode of delivery, and the main disease conditions that are considered by neonatologists as contraindications.
DESIGN: National survey using a questionnaire.
SETTING: 155 neonatal departments in France.
RESULTS: 100 (65%) neonatal departments participated in the survey. The most widely used lipid emulsion was the 20% soybean oil/coconut oil-based emulsion (68% of the units), followed by the soybean oil-based emulsion (28.5%) and the soybean oil/olive oil-based emulsion (3.5%). Peripheral venous access was considered to be a possible route for the infusion of lipid emulsions in only 58 (63.7%) of the units. In 80%-90% of the units, sepsis, hemodynamic failure, thrombocytopenia, disseminated intravascular coagulation, and hyperbilirubinemia were considered to be relative or absolute contraindications, whereas only hemodynamic failure, disseminated intravascular coagulation, and to a lesser extent sepsis were most often perceived as absolute contraindications.
CONCLUSIONS: Neonatologists are somewhat reluctant to use parenteral lipids when only peripheral venous access is available, despite the low osmolarity of the emulsions. This may impair, at least temporarily, the adequate supply of energy and/or essential fatty acids in infants who do not have central venous access. This study also shows a large heterogeneity of responses with regard to the contraindications for parenteral lipids.
DESIGN: National survey using a questionnaire.
SETTING: 155 neonatal departments in France.
RESULTS: 100 (65%) neonatal departments participated in the survey. The most widely used lipid emulsion was the 20% soybean oil/coconut oil-based emulsion (68% of the units), followed by the soybean oil-based emulsion (28.5%) and the soybean oil/olive oil-based emulsion (3.5%). Peripheral venous access was considered to be a possible route for the infusion of lipid emulsions in only 58 (63.7%) of the units. In 80%-90% of the units, sepsis, hemodynamic failure, thrombocytopenia, disseminated intravascular coagulation, and hyperbilirubinemia were considered to be relative or absolute contraindications, whereas only hemodynamic failure, disseminated intravascular coagulation, and to a lesser extent sepsis were most often perceived as absolute contraindications.
CONCLUSIONS: Neonatologists are somewhat reluctant to use parenteral lipids when only peripheral venous access is available, despite the low osmolarity of the emulsions. This may impair, at least temporarily, the adequate supply of energy and/or essential fatty acids in infants who do not have central venous access. This study also shows a large heterogeneity of responses with regard to the contraindications for parenteral lipids.
Mots-clé
Fat Emulsions, Intravenous/administration & dosage, hic" UI="D005602">France, Guidelines as Topic, Humans, Infant, Newborn, Infant, Premature, Intensive Care Units, Neonatal/statistics & numerical data, Intensive Care, Neonatal/methods, Parenteral Nutrition/methods, Patient Compliance, Plant Oils/administration & dosage, Questionnaires, Soybean Oil/administration & dosage
Pubmed
Web of science
Création de la notice
22/02/2015 10:58
Dernière modification de la notice
20/08/2019 15:43
Données d'usage
